Alphamab Oncology9966 
$0.331.57%24h
1.57%24h
Global rank14421
Market cap$320.48M
Change 7d7.47%
YTD Performance-61.23%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Alphamab Oncology (9966)
As of August 2024, Alphamab Oncology has a market cap of $320.48M. This makes Alphamab Oncology the world's 14421th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Alphamab Oncology from 2019 to 2024
-
Value:-
Market cap history of Alphamab Oncology from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $525.89M | -35.99% |
| 2023 | $821.62M | -38.52% |
| 2022 | $1.34B | -20.59% |
| 2021 | $1.68B | -17.27% |
| 2020 | $2.03B | 17.43% |
| 2019 | $1.73B | - |
9966 Market Cap Today is $320.48M 1.57% - 30 Aug 2024
View largest stocks by market cap 
